These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12176516

  • 1. Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up.
    Garcia I, Spanish-Italian Tacrolimus Study Group.
    Transplant Proc; 2002 Aug; 34(5):1638-9. PubMed ID: 12176516
    [No Abstract] [Full Text] [Related]

  • 2. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
    Pascual J, Ortuño J, Spanish and Italian Tacrolimus Study Group.
    Transplant Proc; 2002 Feb; 34(1):89-91. PubMed ID: 11959198
    [No Abstract] [Full Text] [Related]

  • 3. One-year follow-up of a large European trial comparing dual versus triple tacrolimus-based immunosuppressive regimens following renal transplantation.
    Calconi G, Vianello A, Italian and Spanish Tacrolimus Study Group.
    Transplant Proc; 2001 Feb; 33(1-2):1021-4. PubMed ID: 11267173
    [No Abstract] [Full Text] [Related]

  • 4. One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation.
    Campos HH, Abbud Filho M, Brazilian Tacrolimus Study Group.
    Transplant Proc; 2002 Aug; 34(5):1656-8. PubMed ID: 12176523
    [No Abstract] [Full Text] [Related]

  • 5. Comparison between a two-drug regimen with tacrolimus and steroids and a triple one with azathioprine in kidney transplantation: results of a European trial with 3-year follow up.
    Pascual J, Segoloni G, Gonzalez Molina M, del Castillo D, Capdevila L, Arias M, Garcia J, Ortuño J, Spanish-Italian Tacrolimus Study Group.
    Transplant Proc; 2003 Aug; 35(5):1701-3. PubMed ID: 12962764
    [Abstract] [Full Text] [Related]

  • 6. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
    Shapiro R, Scantlebury VP, Jordan ML, Vivas CA, Jain A, Hakala TR, McCauley J, Johnston J, Randhawa P, Fedorek S, Gray E, Chesky A, Dvorchik I, Donaldson J, Fung JJ, Starzl TE.
    Transplant Proc; 2002 Aug; 34(5):1651-2. PubMed ID: 12176521
    [No Abstract] [Full Text] [Related]

  • 7. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
    Forsythe J.
    Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
    [No Abstract] [Full Text] [Related]

  • 8. Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience.
    Lye WC.
    Transplant Proc; 2000 Nov; 32(7):1700-1. PubMed ID: 11119898
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy.
    Lladó L, Figueras J, Ramos E, Baliellas C, Torras J, Rafecas A, Fabregat J, Lama C, Ibañez L, Jaurrieta E.
    Transplant Proc; 2002 Aug; 34(5):1526-8. PubMed ID: 12176468
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
    Morales JM, Andrés A, Morales E, Herrero JC, Cubas A, Praga M, Hernández E, Ortuño T, Dominguez-Gil B, Carreño A, Delgado M, Manzanares C.
    Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
    [No Abstract] [Full Text] [Related]

  • 14. The Benelux experience with the combination of tacrolimus and mycophenolate mofetil.
    Squifflet JP, Van Hooff JP, Vanrenterghem Y.
    Transplant Proc; 1999 Nov; 31(7A):72S-74S. PubMed ID: 10576050
    [No Abstract] [Full Text] [Related]

  • 15. Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
    Claesson K, Mayer AD, Squifflet JP, Grabensee B, Eigler FW, Behrend M, Vanrenterghem Y, van Hooff J, Morales JM, Johnson RW, Buchholz B, Land W, Forsythe JL, Neumayer HH, Ericzon BG, Mühlbacher F.
    Transplant Proc; 1998 Jun; 30(4):1292-4. PubMed ID: 9636524
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Induction versus non-induction protocols in anti-calcineurin-based immunosuppression.
    Charpentier B.
    Transplant Proc; 2001 Jun; 33(7-8):3334-6. PubMed ID: 11750425
    [No Abstract] [Full Text] [Related]

  • 18. Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation.
    Lladó L, Figueras J, Ramos E, Lama C, Busquets J, Ibáñez L, Rafecas A, Fabregat J, Torras J, Jaurrieta E.
    Transplant Proc; 2002 Feb; 34(1):108. PubMed ID: 11959210
    [No Abstract] [Full Text] [Related]

  • 19. Monotherapy with tacrolimus and corticosteroid withdrawal.
    Lauzurica R, Ara J, Fernández P, Bayés B, Bonet J, Romero R.
    Transplant Proc; 2002 Feb; 34(1):120-1. PubMed ID: 11959217
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.